AMPH vs CSX · P/E 12, rev $732.0M vs P/E 19, rev $14.09B
Amphastar P (AMPH) versus CSX Corporation (CSX) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
CSX Corporation (CSX) is a railroads company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Not investment advice. Open the AMPH and CSX stock pages for the full models.
Not investment advice.